Acupuncture
Procedureacupuncture at Zusanli (ST36); sample size: 44
NCT Number: NCT06982755
The investigators designed this clinical study to evaluate the efficacy and safety of semi-standardized acupuncture and moxibustion combined with compound diclofenac sodium injection in the emergency department (ED) compared with acupuncture or compound diclofenac sodium injection alone.
Trial opening soon.
Get Notified16 year–75 year
All sexes
Interventional
Phase 1 / Phase 2
This study is a prospective, parallel-controlled, open-label randomized controlled trial (RCT). The Numeric Rating Scale (NRS) was used to assess pain intensity. The primary outcome measure was the difference in pain response rates between the combined intervention group, the acupuncture-only group, and the diclofenac sodium combination group at 10 minutes post-treatment compared to baseline. Secondary outcomes included treatment response rates, NRS scores, pain recurrence rates, rescue medication rates, and adverse events at each observation time point across the three groups. Additionally, a placebo group was included to exploratorily assess the placebo effect of the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(4)Those who were considered not to need surgery within 2 hours after initial assessment by a specialist.
Exclusion criteria
Participants meeting any of the following criteria were excluded from the study:
acupuncture at Zusanli (ST36); sample size: 44
intramuscular injection of compound diclofenac sodium injection; sample size: 44
Other names: compound Diclofenac Sodium Injection
acupuncture at Zusanli (ST36) and intramuscular injection of compound diclofenac sodium injection; sample size: 44
superficial acupuncture at Zusanli (ST36) and intramuscular injection of normal saline; sample size: 44
Time frame: at 10 minutes after analgesia
Using the Numeric Rating Scale (NRS) score evaluate the proportion of individuals within the group who achieved a therapeutic index of ≥50% at the 10th minute post-treatment compared to baseline
Time frame: within 1 hour to 1 day post-analgesia
If the subject still experiences intolerable pain (NRS ≥ 4) after 1 hour of treatment or following supplemental treatment, additional analgesic medications such as Rotundine or Dezocine shall be administered. Furthermore, subjects who still exhibit "severe pain" after 1 hour of treatment will be given rescue analgesic medication: Pethidine Hydrochloride Injection, 25 mg, intramuscularly (to be prescribed by a supervising physician with the qualifications to prescribe narcotic drugs).
Time frame: baseline
In this study, a Likert scale was utilized to construct a specialized questionnaire aimed at assessing patients' expectations of the intervention. The questionnaire consists of four items designed to evaluate patients' anticipations regarding the intervention's efficacy in alleviating symptoms, its onset of action, potential side effects, and its impact on quality of life. Each item is scored on a five-point scale, ranging from 1 (strongly disagree) to 5 (strongly agree). At baseline, the ratings for each item were determined according to the personal expectations of the patients. To provide a comprehensive reflection of patients' overall expectations of the intervention, each item is assigned equal weight in the total score calculation. The scores of the four items are summed to yield a total score, which quantifies patients' overall expectations of the intervention.
Time frame: at 1 day after analgesia
In this study, a Likert scale was employed to develop a specialized questionnaire designed to assess patient satisfaction with the intervention. The questionnaire comprehensively evaluates patient satisfaction across multiple dimensions, including satisfaction with the treatment process, experience of side effects, and overall satisfaction. Each dimension is rated on a five-point scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The items in the questionnaire were rated by patients based on their actual experiences on the first day after the intervention. To provide a comprehensive reflection of patients' overall satisfaction with the intervention, each item carries equal weight in the total score calculation. The scores of all items are summed to yield a total score, which quantifies the patients' overall satisfaction with the intervention.
Time frame: at 0, 1, 5, 10, 20, 30, and 60 minutes, and at 1 and 3 days post-analgesia
Numeric Rating Scale
Time frame: at 1 day after analgesia
Recurrence rate of pain within 1 day in the four groups: NRS score ≤2 after the initial intervention pain recurrence within 1 day and occurrence of NRS score ≥4.
Time frame: through study completion, an average of 3 days
During the entire treatment period and follow-up period: Adverse events were evaluated immediately after the intervention, at 0, 1, 5, 10, 20, 30, and 60 minutes after the treatment, and during the follow-up periods on the first and third days after the intervention. The frequency of adverse events in each group was recorded, and the proportion of adverse events was calculated.
Contact information is provided by the study sponsor or research team.
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Other
Effect of Acupuncture on Early Analgesia of Non-traumatic Acute Abdomen is Discussed Based on the Experience of Sanli Acupoint for Du-fu Diseases :A Prospective Randomized Controlled pRCT Study
Acronym: ACU-NTAA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02399150
Abdomen, Acute, Abdominal Pain
Paris, France
View Trial DetailsNCT07123805
Acupuncture, Acupuncture Analgesia
Pavia, Italy
View Trial DetailsNCT07656025
Acupuncture, Brain Diseases
View Trial DetailsNCT07522567
Acupuncture, Auditory Brainstem Response
View Trial Details